Overview
Semler Scientific Inc. is a company specializing in the development and commercialization of proprietary technologies and products that assist healthcare providers in evaluating and managing chronic diseases
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Semler Scientific, Inc. as of June 30, 2025 is 42.98 MM.
- The operating income for Semler Scientific, Inc. as of June 30, 2025 is 5.20 MM.
- The net income for Semler Scientific, Inc. as of June 30, 2025 is 37.05 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 42.98 | 5.20 | 37.05 |
2025-03-31 | 49.23 | 12.61 | -29.88 |
2024-12-31 | 56.29 | 20.93 | 40.90 |
2024-09-30 | 58.94 | 20.05 | 15.91 |
2024-06-30 | 61.74 | 24.36 | 15.82 |
2024-03-31 | 65.88 | 26.19 | 21.69 |
2023-12-31 | 68.18 | 25.47 | 20.58 |
2023-09-30 | 66.92 | 23.95 | 19.58 |
2023-06-30 | 64.65 | 21.52 | 17.74 |
2023-03-31 | 60.88 | 19.52 | 15.93 |
2022-12-31 | 56.69 | 17.20 | 14.32 |
2022-09-30 | 54.43 | 15.30 | 12.62 |
2022-06-30 | 54.38 | 16.08 | 13.09 |
2022-03-31 | 53.86 | 17.37 | 15.71 |
2021-12-31 | 53.03 | 19.45 | 17.22 |
2021-09-30 | 53.56 | 23.73 | 21.11 |
2021-06-30 | 50.29 | 24.03 | 21.82 |
2021-03-31 | 42.36 | 18.53 | 16.21 |
2020-12-31 | 38.60 | 15.96 | 14.01 |
2020-09-30 | 35.68 | 13.01 | 11.45 |
Income Statement: EPS
- The earnings per share basic for Semler Scientific, Inc. as of June 30, 2025 is 4.07.
- The earnings per share diluted for Semler Scientific, Inc. as of June 30, 2025 is 3.71.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | 4.07 | 3.71 |
2025-03-31 | -3.78 | -3.77 |
2024-12-31 | 5.66 | 5.13 |
2024-09-30 | 2.30 | 2.04 |
2024-06-30 | 2.31 | 2.03 |
2024-03-31 | 3.20 | 2.78 |
2023-12-31 | 3.06 | 2.63 |
2023-09-30 | 2.92 | 2.50 |
2023-06-30 | 2.65 | 2.25 |
2023-03-31 | 2.38 | 2.01 |
2022-12-31 | 2.13 | 1.79 |
2022-09-30 | 1.87 | 1.57 |
2022-06-30 | 1.94 | 1.62 |
2022-03-31 | 2.33 | 1.93 |
2021-12-31 | 2.56 | 2.12 |
2021-09-30 | 3.15 | 2.60 |
2021-06-30 | 3.27 | 2.69 |
2021-03-31 | 2.45 | 2.01 |
2020-12-31 | 2.13 | 1.74 |
2020-09-30 | 1.75 | 1.44 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Semler Scientific, Inc. as of June 30, 2025 is 12.46 MM.
- The cash from investing activities for Semler Scientific, Inc. as of June 30, 2025 is -366.41 MM.
- The cash from financing activities for Semler Scientific, Inc. as of June 30, 2025 is 360.10 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 12.46 | -366.41 | 360.10 |
2025-03-31 | 16.88 | -277.21 | 207.32 |
2024-12-31 | 24.41 | -189.98 | 117.19 |
2024-09-30 | 21.43 | -50.35 | -1.87 |
2024-06-30 | 19.83 | -48.70 | -3.17 |
2024-03-31 | 26.09 | 36.74 | -5.25 |
2023-12-31 | 21.33 | 18.40 | -5.41 |
2023-09-30 | 18.60 | -24.54 | -2.10 |
2023-06-30 | 21.79 | -18.25 | -4.07 |
2023-03-31 | 16.82 | -45.00 | -4.94 |
2022-12-31 | 17.46 | -26.84 | -4.94 |
2022-09-30 | 17.41 | -2.75 | -5.05 |
2022-06-30 | 17.03 | -2.49 | -3.02 |
2022-03-31 | 12.95 | -0.86 | -0.14 |
2021-12-31 | 16.06 | -0.82 | 0.01 |
2021-09-30 | 19.95 | -0.92 | 0.11 |
2021-06-30 | 15.82 | -1.16 | 0.20 |
2021-03-31 | 16.02 | -0.99 | 0.24 |
2020-12-31 | 15.11 | -1.01 | 0.23 |
2020-09-30 | 13.20 | -1.18 | -3.77 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Management Effectiveness
- The roa for Semler Scientific, Inc. as of June 30, 2025 is 0.77.
- The roe for Semler Scientific, Inc. as of June 30, 2025 is 1.07.
- The roic for Semler Scientific, Inc. as of June 30, 2025 is 0.46.
- The croic for Semler Scientific, Inc. as of June 30, 2025 is 0.47.
- The ocroic for Semler Scientific, Inc. as of June 30, 2025 is 0.51.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2025-03-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2024-12-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2024-09-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2024-06-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2024-03-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2023-12-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2023-09-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2023-06-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2023-03-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2022-12-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2022-09-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2022-06-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2022-03-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2021-12-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2021-09-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2021-06-30 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2021-03-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2020-12-31 | 0.77 | 1.07 | 0.46 | 0.47 | 0.51 |
2020-09-30 | 0.61 | 0.81 | 0.51 | 0.37 | 0.59 |
Gross Margins
- The gross margin for Semler Scientific, Inc. as of June 30, 2025 is 0.91.
- The net margin for Semler Scientific, Inc. as of June 30, 2025 is 0.36.
- The operating margin for Semler Scientific, Inc. as of June 30, 2025 is 0.41.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.91 | 0.36 | 0.41 |
2025-03-31 | 0.91 | 0.36 | 0.41 |
2024-12-31 | 0.91 | 0.36 | 0.41 |
2024-09-30 | 0.91 | 0.36 | 0.41 |
2024-06-30 | 0.91 | 0.36 | 0.41 |
2024-03-31 | 0.91 | 0.36 | 0.41 |
2023-12-31 | 0.91 | 0.36 | 0.41 |
2023-09-30 | 0.91 | 0.36 | 0.41 |
2023-06-30 | 0.91 | 0.36 | 0.41 |
2023-03-31 | 0.91 | 0.36 | 0.41 |
2022-12-31 | 0.91 | 0.36 | 0.41 |
2022-09-30 | 0.91 | 0.36 | 0.41 |
2022-06-30 | 0.91 | 0.36 | 0.41 |
2022-03-31 | 0.91 | 0.36 | 0.41 |
2021-12-31 | 0.91 | 0.36 | 0.41 |
2021-09-30 | 0.91 | 0.36 | 0.41 |
2021-06-30 | 0.91 | 0.36 | 0.41 |
2021-03-31 | 0.91 | 0.36 | 0.41 |
2020-12-31 | 0.91 | 0.36 | 0.41 |
2020-09-30 | 0.91 | 0.32 | 0.36 |
Identifiers and Descriptors
Central Index Key (CIK) | 1554859 |
Industry Groups
SIC 3845 - Electromedical and Electrotherapeutic Apparatus |